Literature DB >> 8617789

Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis.

K Yokote1, S Mori, A Siegbahn, L Rönnstrand, C Wernstedt, C H Heldin, L Claesson-Welsh.   

Abstract

Activation of the platelet-derived growth factor (PDGF) beta-receptor leads to cell growth and chemotaxis. The PDGF alpha-receptor also mediates a mitogenic signal, but fails to induce cell migration in certain cell types. To examine this difference in signal transduction, a series of point-mutated PDGF alpha-receptors were analyzed. Porcine aortic endothelial cells expressing mutant PDGF alpha-receptors, in which tyrosine residues 768, 993, or 1018 were changed to phenylalanine residues migrated toward PDGF, whereas wild-type alpha-receptors and mutant alpha-receptors changed at tyrosine residues 720, 944, or 988 failed to migrate. All mutant receptors were mitogenically active and their capacity to activate phosphatidylinositol 3'-kinase and phospholipase C-gamma was not different from that of the wild-type receptor. Tyr-768 was found to be phosphorylated in PDGF-stimulated cells; in the Y768F mutant, there was a considerable increase in phosphorylation of Ser-767. Tyr-993 was not phosphorylated, but mutation of this tyrosine residue to a phenylalanine residue resulted in increased efficiency of phosphorylation on Tyr-988. Tyr-1018 is known to be an autophosphorylation site. Phosphorylated Tyr-768 and Tyr-1018 may bind signal transduction molecules involved in negative modulation of the chemotactic signaling capacity, whereas phosphorylated Tyr-988 may mediate increased chemotaxis. Thus our data indicate that the PDGF alpha-receptor has an intrinsic ability to transduce a chemotactic signal, and that this signal is counteracted by overriding negative signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617789     DOI: 10.1074/jbc.271.9.5101

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The heparin-binding site of antithrombin is crucial for antiangiogenic activity.

Authors:  Weiqing Zhang; Richard Swanson; Gonzalo Izaguirre; Yan Xiong; Lester F Lau; Steven T Olson
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

2.  Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function.

Authors:  Johan Kreuger; Taro Matsumoto; Maarten Vanwildemeersch; Takako Sasaki; Rupert Timpl; Lena Claesson-Welsh; Dorothe Spillmann; Ulf Lindahl
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

3.  Platelet-derived-growth-factor-induced signalling in human platelets: phosphoinositide-3-kinase-dependent inhibition of platelet activation.

Authors:  F Selheim; M H Fukami; H Holmsen; F S Vassbotn
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

4.  Retention of PDGFR-beta function in mice in the absence of phosphatidylinositol 3'-kinase and phospholipase Cgamma signaling pathways.

Authors:  M D Tallquist; R A Klinghoffer; R Heuchel; P F Mueting-Nelsen; P D Corrin; C H Heldin; R J Johnson; P Soriano
Journal:  Genes Dev       Date:  2000-12-15       Impact factor: 11.361

5.  A common phosphotyrosine signature for the Bcr-Abl kinase.

Authors:  Valerie L Goss; Kimberly A Lee; Albrecht Moritz; Julie Nardone; Erik J Spek; Joan MacNeill; John Rush; Michael J Comb; Roberto D Polakiewicz
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

6.  Disruption of PDGFRalpha-initiated PI3K activation and migration of somite derivatives leads to spina bifida.

Authors:  Elizabeth A Pickett; Gregory S Olsen; Michelle D Tallquist
Journal:  Development       Date:  2008-02       Impact factor: 6.868

7.  PDGF receptor-{beta} modulates metanephric mesenchyme chemotaxis induced by PDGF AA.

Authors:  Jill M Ricono; Brent Wagner; Yves Gorin; Mazen Arar; Andrius Kazlauskas; Goutam Ghosh Choudhury; Hanna E Abboud
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-19

8.  Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblasts.

Authors:  Johanna Donovan; Xu Shiwen; Jill Norman; David Abraham
Journal:  Fibrogenesis Tissue Repair       Date:  2013-05-10

9.  MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.

Authors:  Jino Park; Soojin Kim; Joongho Joh; Scot C Remick; Donald M Miller; Jun Yan; Zeyad Kanaan; Ju-Hsien Chao; Maxwell M Krem; Soumit K Basu; Shotaro Hagiwara; Lukas Kenner; Richard Moriggl; Kevin D Bunting; William Tse
Journal:  Oncotarget       Date:  2016-07-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.